DERIVATIVE LIABILITY AND UNREALIZED GAIN- Additional Information (Detail) (USD $)	1 Months Ended			3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 21, 2011	Sep. 09, 2011	Feb. 28, 2011	Dec. 31, 2012	Dec. 30, 2011	Dec. 31, 2012	Dec. 31, 2011	Mar. 31, 2012
Fair Value of Financial Instruments [Line Items]
Common stock shares issued to acquire patent			44,254,952
Common stock, shares issuable			31,610,544
Minimum Proceeds from issuance of debt and/or equity in order to issue shares to sellers of patent		$ 20,000,000	$ 20,000,000
Agreement cancellation period	1 year
Number of shares issued	55,318,920
Number of shares to be repurchased	55,318,920					55,318,920
Fair value of price per share	$ 0.40					$ 0.02
Stock restriction period	1 year
Percentage of shares to be repurchased				100.00%		100.00%	15.00%	100.00%
Derivative liability				0		0	3,319,135	5,531,892
Agreement expiration date				Oct. 21, 2012				Oct. 21, 2012
Unrealized gain on fair value of derivative				4,425,514	0	(5,531,892)	0
L.Y. Hong Kong Biotech Limited
Fair Value of Financial Instruments [Line Items]
Unrealized gain on fair value of derivative				1,106,378
Patent (U.S. No. 6,475,531 B1)
Fair Value of Financial Instruments [Line Items]
Minimum Proceeds from issuance of debt and/or equity in order to issue shares to sellers of patent		20,000,000
Patent (U.S. No. 6,475,531 B1) | L.Y. Hong Kong Biotech Limited
Fair Value of Financial Instruments [Line Items]
Common stock shares issued to acquire patent			44,254,952
Common stock, shares issuable			31,610,544
Patent (U.S. No. 6,475,531 B1) | L.Y. Hong Kong Biotech Limited | Minimum
Fair Value of Financial Instruments [Line Items]
Minimum Proceeds from issuance of debt and/or equity in order to issue shares to sellers of patent			$ 20,000,000
Patent (U.S. No. 6,475,531 B1) | L.Y. Hong Kong Biotech Limited | Scenario 1
Fair Value of Financial Instruments [Line Items]
Common stock, shares issuable			11,063,968
Patent (U.S. No. 6,475,531 B1) | L.Y. Hong Kong Biotech Limited | Scenario 2
Fair Value of Financial Instruments [Line Items]
Common stock, shares issuable			20,546,711